Last updated: Nov 20, 2026, 12:00 AM

Akari Therapeutics PLC Exchange (NASDAQ, USD)

AKTX

5.70
-0.81 (-12.44%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
977.91%
3 year return (CAGR)
17.60%
5 year return (CAGR)
-29.70%
10 year return (CAGR)
-28.85%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
13.03M
Price/Sales
-
Ent value
25.36M
Price/Book
0.70
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
116.46%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open6.11
Daily high6.26
Daily low5.70
Daily Volume11K
All-time high5000.00
1y analyst estimate25.50
Beta1.47
EPS (TTM)-17.28
Dividend per share0.00
Ex-div date-
Next earnings date-

Ready to capitalize on Akari Therapeutics PLC's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
AKTXS&P500
Current price drop from All-time high-99.89%-5.99%
Highest price drop-100.00%-56.47%
Date of highest drop30 Mar 20269 Mar 2009
Avg drop from high-96.64%-10.64%
Avg time to new high1586 days12 days
Max time to new high3172 days1805 days